Regeneron Pharmaceuticals, Inc. (VIE:REGN)
Austria · Delayed Price · Currency is EUR 665.00
+0.40 (0.06%)
At close: Dec 23, 2025
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of €68.28 billion as of December 24, 2025. Its market cap has decreased by -14.79% in one year.
Market Cap
68.28B
Enterprise Value
54.68B
Revenue
12.14B
Ranking
n/a
PE Ratio
17.50
Stock Price
€665.00
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 68.28B, an increase of 51,861.23%. That is a compound annual growth rate of 20.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 68.28B | -7.76% |
| Dec 31, 2024 | 74.03B | -12.40% |
| Dec 29, 2023 | 84.50B | 17.20% |
| Dec 30, 2022 | 72.10B | 24.19% |
| Dec 31, 2021 | 58.06B | 39.28% |
| Dec 31, 2020 | 41.68B | 13.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erste Group Bank AG | 38.99B |
| VERBUND AG | 21.42B |
| OMV Aktiengesellschaft | 15.40B |
| Raiffeisen Bank International AG | 12.25B |
| BAWAG Group AG | 9.67B |
| Strabag SE | 9.19B |
| Vienna Insurance Group AG | 8.45B |
| Andritz AG | 6.42B |